Merger and acquisition activity remains high in the industry and two major Canadian firms – Sundial Growers and Canopy Growth – have made acquisitions this month ...
CBD-Intel assesses how Project Twenty21 is faring as it seeks to construct a registry of medical cannabis users in the UK and Europe, providing real world data on potential efficacy ...
Despite the island state's generally liberal outlook, and long association with cannabis culture, legalisation of recreational use remains a frustrated dream for many in Hawaii ...
Early moves towards a regulatory framework that would allow a cannabinoid industry in Argentina have been welcomed by insiders who hope ultimately to match or surpass the progress made by other South American nations ...
The boss of the world’s new largest global cannabis company has likened the industry’s potential to that of the alcohol business before the ending of Prohibition in the early 1930s ...
A CBD company has been fined more than $30,000 by the US Federal Trade Commission (FTC) in the first such punishment since a crackdown on false or misleading health claims was announced in December ...
US cannabis firm Trulieve has bought Harvest Health and Recreation in a $2.1bn deal that aims to create the US’s most profitable cannabis company in what is being billed as the largest US cannabis transaction...
Pain is a familiar part of everybody’s life, yet it remains a remarkably hard subject to study. It therefore is unsurprising that studies have come to differing conclusions on the use of cannabis and cannabinoids...
Two US firms, Greenlane and KushCo, have merged in a deal that aims to create a major manufacturer and distributor of cannabis accessories in the US ...
Significant cannabis reform is inevitably coming to congress, no matter whether the Biden administration considers it a priority, and giants in experienced lobbying industries are preparing their agents ...
When Biden won the US election in November 2020 the stock market value of cannabis firms soared in expectation of a more lenient political climate under the Biden administration ...
Various business deals across the US and Canada see cannabis and CBD companies expanding their portfolios and growing their brands in a series of acquisitions, investments and partnerships ...
With federal elections due in September, Germany’s Free Democratic Party (FDP) has called on the government to draft a law permitting the controlled distribution of cannabis for adult use ...
South Africa releases the National Cannabis Master Plan, which will not only boost and uplift the southern Africa cannabis industry, but will set a regional precedent for the growth of a legal cannabis market in the area ...
Poland’s Parliamentary Team for the Legalisation of Marijuana has submitted a package of three draft bills to the speaker of parliament’s lower chamber, following a public consultation on the proposals ...
CBD-Intel offers a review of the science behind some of cannabis’s lesser-known compounds – the so-called “minor cannabinoids” – with an emphasis on their potential applications ...
Early research into the possibility of CBD having a role to play in the fight against coronavirus infections has shown some initial promise. Any practical application remains a long way off, however ...
Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria ...
Jersey could become “a cannabis hub for Europe” after Northern Leaf successfully completed a second round of funding that will enable it to complete its pharmaceutical cannabis cultivation facility on the island ...
A new deputy commissioner at the US Food and Drug Administration (FDA) will likely be the single person with the most influence on the path to market for CBD in the US ...
While legal cannabis is still a relatively new industry, investors are already looking for the next sector to boom – and many think that will be psychedelics ...
Access to banking services has been a problem for the legal cannabis sector in the US from the beginning – and the experience of one cooperative in Michigan shows that the relationship can be problematic...
The US Customs and Border Protection (CBP) agency is wrongly seizing legal hemp and hemp-related shipments – such as farm equipment that it claims constitutes drug paraphernalia – according to two recently-filed lawsuits ...
Mexico’s Senate is poised to request extra time to approve legislation that would legalise cannabis in the country, prolonging debate over the highly anticipated bill until September ...
Canadian cannabis firm Tilray is moving in on New Zealand’s market for medical cannabis and has received the necessary approvals to launch Tilray medical cannabis products across the country ...
Suggestions that a Chinese ban on the use of CBD in cosmetics that would essentially shut down the domestic CBD market, blocking imports and cross-border online sales, appear to be premature ...
It’s been a long process getting there, but the last US state to legalise industrial hemp finally has a bill headed to the governor’s desk and farmers poised to plant the crop ...
Scientific findings on the antimicrobial properties of cannabis – and in particular cannabinoids – have raised the question of whether they might play a role in combatting antibiotic-resistant bacteria such as MRSA ...
States continue to update their hemp production plans to match US Department of Agriculture (USDA) final rule requirements, with Michigan being one of the latest ...
Italy’s Ministry of Health and the Italian Medicine Agency (AIFA) have begun authorising Italian companies to manufacture hemp-derived CBD extracts for pharmaceutical purposes ...
The newest cannabinoid craze is stirring up controversy in the emerging legal hemp industry. Delta-8 THC, produced from hemp-extracted CBD, promises a legal high – but, many wonder, at what cost? ...
Germany’s highest civil and criminal court has ruled that low-THC industrial hemp flowers may be considered a narcotic – but that they can be legally sold to German consumers if there is no risk of...
CBD companies see more synergies than threats from the provision of legal cannabis products in states such as Colorado, which has one of the oldest recreational cannabis markets in the US ...
There are profits to be made from selling cannabis in Europe, according to US company Curaleaf after it signed an agreement to acquire Europe’s largest vertically integrated independent cannabis company ...
A lab technician’s slip-up five decades ago could cause a complete rethink of cannabis and CBD regulation in many jurisdictions, legal scholars warned today ...
The British Hemp Alliance (BHA) has contested the suggestion put forward by the Association for the Cannabinoid Industry (ACI) for allowable THC levels in CBD products, claiming it would only benefit “the big boys” ...
The US Food and Drug Administration (FDA) has assessed a combined health claim for the first time and denounced the practice of promoting CBD on a product making qualified health claims based on other...
An Oregon senator believes he has found a solution to the cannabis banking crisis in the state, and perhaps set a useful standard for others across the US ...
The US Food and Drug Administration (FDA) has told two CBD companies they fell short of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals and ordered them to undertake proper testing ...
The CEO of one company targeted by the US Federal Trade Commission (FTC) in the first ever group of fines handed down by the government agency to CBD companies considers the event to be a...
Industry reaction to the change in UK Food Standards Agency (FSA) novel food submission requirements is mixed, some welcoming it while others say it reveals failings of management and understanding ...
Cannabis giant Canopy Growth has defended its decision to use a celebrity astrologer to promote the US launch of its CBD-infused sparkling water drink Quatreau ...
No evidence of liver toxicity from CBD has been found in the ValidCare study, the results of which have been given to the US Food and Drug Administration (FDA) for review ...
A drop in the cost of bulk CBD has not yet been wholly reflected in falling CBD product prices – but are we about to witness a perfect storm for a race to the...
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.